The Development of an AAV-Based CRISPR SaCas9 Genome Editing System That Can Be Delivered to Neurons in Vivo and Regulated via Doxycycline and Cre-Recombinase

Frontiers in Molecular Neuroscience - Switzerland

doi 10.3389/fnmol.2018.00413